Related Experiment Video
Updated: Jan 16, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
A Case Report of Progressive Multifocal Leukoencephalopathy (PML) in an Immunocompetent Patient
Kazi Subrina Nazneen1, Nicole Mascarenhas1, Eiman Elsheikh1
1Acute Medicine, General Internal Medicine, Medway NHS Foundation Trust, Gillingham, GBR.
Abstract:
Progressive multifocal leukoencephalopathy (PML) is a rare but fatal demyelinating disorder resulting from reactivation of latent John Cunningham virus (JCV), which induces demyelinating lytic infection of oligodendrocytes. We report a case of PML in an individual without identifiable immunodeficiency who presented with insidious and progressive deficits in speech and motor function. Diagnostic workup revealed JC viral DNA in cerebrospinal fluid, and magnetic resonance imaging (MRI) demonstrated multiple asymmetric lesions within the subcortical and deep white matter. Despite administration of the immune checkpoint inhibitor pembrolizumab, the patient's neurological status continued to decline, culminating in death. This case underscores the necessity of considering PML in the differential diagnosis of patients lacking classic risk factors when clinical presentation and neuroimaging findings are indicative of demyelinating pathology.
Insights
Progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease, can occur without known immunodeficiency. This case highlights the importance of considering PML in unexplained neurological decline, even in atypical presentations.
Area of Science:
- Neurology
- Virology
- Immunology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, fatal demyelinating disease.
- It is caused by reactivation of the John Cunningham virus (JCV), leading to oligodendrocyte infection.
- PML typically occurs in immunocompromised individuals.

